Senior insider sale
Corporate Controller at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$286.4K
21.83K shares
What this filing means
PISKEL KYLE plans to sell 21.83K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $286.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/16/2026ACC: 0001780662-26-000010
Officer· Corporate Controller
Since Jun 2019
21.83K
Shares to sell
$286.4K
Approx. market value
3.16K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/15/2026
3.16KTotal acquired3.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Units N/A | 3.16K | — |
| Total | 3.16K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
18.67K
Market value
$245.9K
3/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.16K
Market value
$40.5K
5/18/2026
Total
Units
21.83K
Value
$286.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/11/2026 | 18.67K | $245.9K | — | Completed |
| Planned — Approximate Date | ||||
5/18/2026 | 3.16K | $40.5K | NASDAQ | Planned |
| Total | 21.83K | $286.4K | ||